These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8430863)

  • 1. Action of C-type natriuretic peptide in isolated canine arteries and veins.
    Wei CM; Aarhus LL; Miller VM; Burnett JC
    Am J Physiol; 1993 Jan; 264(1 Pt 2):H71-3. PubMed ID: 8430863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of relaxations to C-type natriuretic peptide in veins.
    Banks M; Wei CM; Kim CH; Burnett JC; Miller VM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1907-11. PubMed ID: 8945908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
    Wei CM; Kim CH; Khraibi AA; Miller VM; Burnett JC
    Hypertension; 1994 Jun; 23(6 Pt 2):903-7. PubMed ID: 8206626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
    Wei CM; Kim CH; Miller VM; Burnett JC
    J Clin Invest; 1993 Oct; 92(4):2048-52. PubMed ID: 8408658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.
    Nazario B; Hu RM; Pedram A; Prins B; Levin ER
    J Clin Invest; 1995 Mar; 95(3):1151-7. PubMed ID: 7883964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.
    Barber MN; Gaspari TA; Kairuz EM; Dusting GJ; Woods RL
    J Vasc Res; 2005; 42(2):101-10. PubMed ID: 15665545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].
    Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT
    Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries.
    Barber DA; Burnett JC; Fitzpatrick LA; Sieck GC; Miller VM
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):5-11. PubMed ID: 9676714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide.
    Kawai Y; Ohhashi T
    Can J Physiol Pharmacol; 1989 Apr; 67(4):326-30. PubMed ID: 2527081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats.
    Klinger JR; Siddiq FM; Swift RA; Jackson C; Pietras L; Warburton RR; Alia C; Hill NS
    Am J Physiol; 1998 Oct; 275(4):L645-52. PubMed ID: 9755096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.
    Hammerer-Lercher A; Fersterer J; Holzmann S; Bonatti J; Ruttmann E; Hoefer D; Mair J; Puschendorf B
    Clin Sci (Lond); 2006 Sep; 111(3):225-31. PubMed ID: 16709152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in ANP responsiveness of normal and hypertensive porcine intrapulmonary arteries during maturation.
    Matsushita T; Hislop AA; Boels PJ; Deutsch J; Haworth SG
    Pediatr Res; 1999 Oct; 46(4):411-8. PubMed ID: 10509361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue.
    Protter AA; Wallace AM; Ferraris VA; Weishaar RE
    Am J Hypertens; 1996 May; 9(5):432-6. PubMed ID: 8735173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C type natriuretic peptide is a vasodilator in vivo and in vitro in the common dogfish.
    Bjenning C; Takei Y; Watanabe TX; Nakajima K; Sakakibara S; Hazon N
    J Endocrinol; 1992 May; 133(2):R1-4. PubMed ID: 1535362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor proteins and biological effects of C-type natriuretic peptides in the renal glomerulus of the rat.
    Brown J; Zuo Z
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1383-94. PubMed ID: 8184983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the antianginal drug nicorandil on canine arteries and veins.
    Morrison KJ; Flavahan NA; Vanhoutte PM
    J Cardiovasc Pharmacol; 1990 May; 15(5):791-8. PubMed ID: 1692940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide: a selective cardiovascular peptide.
    Clavell AL; Stingo AJ; Wei CM; Heublein DM; Burnett JC
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R290-5. PubMed ID: 8383462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.